Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Taltobulin hydrochloride is a synthetic analogue of the tripeptide hemiasterlin, is a potent agent of antimicrotubule that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 1,990 | 待询 | ||
10 mg | ¥ 3,095 | 待询 | ||
50 mg | ¥ 9,385 | 待询 | ||
100 mg | 待询 | 待询 | ||
200 mg | 待询 | 待询 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,230 | 待询 |
Taltobulin hydrochloride (228266-40-8 free base) 的其他形式现货产品:
产品描述 | Taltobulin hydrochloride is a synthetic analogue of the tripeptide hemiasterlin, is a potent agent of antimicrotubule that circumvents P-glycoprotein-mediated resistance in vitro and in vivo. |
体外活性 | The growth of 18 tumor cell lines (leukemia, ovarian, NSCLC, breast, colon, and melanoma cell lines) inhibited by Taltobulin (HTI-286; 0.2-7.3 nM; 3 days)(with an average IC50 of 2.5±2.1 nM and a median value of 1.7 nM). |
体内活性 | In athymic nu/nu female mice, Taltobulin (HTI-286; 1.6 mg/kg i.v.) inhibits the growth of human tumor xenografts (e.g., HCT-15, DLD-1, MX-1W, and KB-8-5) . Taltobulin (HTI-286; 3 mg/kg; p.o. gavage) inhibits growth by 97.3 % and 82% in athymic nu/nu female mice with Lox melanoma xenografts and KB-3-1 epidermoid xenograft model, respectively. |
别名 | SPA-110 hydrochloride, Taltobulin hydrochloride, HTI-286 hydrochloride |
分子量 | 510.11 |
分子式 | C27H44ClN3O4 |
CAS No. | T13073L |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (196.04 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.9604 mL | 9.8018 mL | 19.6036 mL | 49.009 mL |
5 mM | 0.3921 mL | 1.9604 mL | 3.9207 mL | 9.8018 mL | |
10 mM | 0.196 mL | 0.9802 mL | 1.9604 mL | 4.9009 mL | |
20 mM | 0.098 mL | 0.4901 mL | 0.9802 mL | 2.4505 mL | |
50 mM | 0.0392 mL | 0.196 mL | 0.3921 mL | 0.9802 mL | |
100 mM | 0.0196 mL | 0.098 mL | 0.196 mL | 0.4901 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Taltobulin hydrochloride (228266-40-8 free base) T13073L Others SPA110 Hydrochloride SPA-110 hydrochloride Taltobulin hydrochloride 228266-40-8 SPA-110 Hydrochloride HTI 286 Hydrochloride Taltobulin hydrochloride (228266408 free base) HTI-286 hydrochloride Taltobulin hydrochloride (228266 40 8 free base) Taltobulin Hydrochloride HTI286 Hydrochloride HTI-286 Hydrochloride 228266-40-8 free base SPA 110 Hydrochloride Inhibitor inhibitor inhibit